Results 151 to 160 of about 76,712 (310)

A Randomized, Double‐Blind, Placebo‐Controlled, Sixteen‐Week Study of Subcutaneous Golimumab in Patients With Active Nonradiographic Axial Spondyloarthritis [PDF]

, 2015
Joachim Sieper, Désirée van der Heijde, Maxime Dougados, Walter P. Maksymowych, B. B. Scott, Judith A. Boice, Yuliya Berd, G. Bergman, Sean Curtis, Anjela Tzontcheva, Susan Huyck, Hsu‐Huei Weng   +11 more
openalex   +1 more source

OP0254 FACTORS ASSOCIATED WITH THE SEVERITY OF COVID-19 INFECTION IN PATIENTS WITH SPONDYLOARTHRITIS: RESULTS OF THE FRENCH RMD COVID-19 COHORT [PDF]

, 2022
Léa Perrot, L. Boyer, R. M. Flipo, H. Marotte, E. Pertuiset, Christian Richard, T. Thomas, R. Seror, P. Chazerain, R. Nicolas, C. Richez, T. Pham   +11 more
openalex   +1 more source

Efficacy and Safety of Ixekizumab in the Treatment of Radiographic Axial Spondyloarthritis: Sixteen‐Week Results From a Phase III Randomized, Double‐Blind, Placebo‐Controlled Trial in Patients With Prior Inadequate Response to or Intolerance of Tumor Necrosis Factor Inhibitors

Arthritis & Rheumatology, 2019
To investigate the efficacy and safety of ixekizumab in patients with active radiographic axial spondyloarthritis (SpA) and prior inadequate response to or intolerance of 1 or 2 tumor necrosis factor inhibitors (TNFi).
A. Deodhar, D. Poddubnyy, C. Pacheco-Tena, C. Salvarani, E. Lespessailles, P. Rahman, P. Järvinen, J. Sánchez-Bursón, K. Gaffney, E. Lee, E. Krishnan, Silvia Santisteban, Xiaoqi Li, F. Zhao, H. Carlier, J. Reveille   +15 more
semanticscholar   +1 more source

Early axial spondyloarthritis [PDF]

Current Opinion in Rheumatology, 2010
To summarize recent advances in the classification of preradiographic axial spondyloarthritis (SpA).Inflammation in the sacroiliac joints precedes radiographic damage that is necessary to establish a diagnosis of ankylosing spondylitis (AS). Preradiographic axial SpA refers to patients with SpA who exhibit signs and symptoms of axial involvement, but ...
openaire   +2 more sources

Bimekizumab plus topical photochemotherapy effective in palmoplantar pustulosis in a patient with hidradenitis suppurativa

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Neda Cramer, Johannes Mohr, Michael P. Schön, Rotraut Mössner   +3 more
wiley   +1 more source

Beyond Inflammation: Why Understanding the Brain Matters in Inflammatory Arthritis

Arthritis Care &Research, Volume 78, Issue 1, Page 3-14, January 2026.
Persistent pain remains a major challenge in inflammatory arthritis, even when joint inflammation is well controlled. Pain and associated symptoms such as fatigue cannot be explained by peripheral inflammation alone but reflect altered central pain processing. These changes may arise through “top‐down” mechanisms, reflecting pre‐existing dysfunction in
Eoin M. Kelleher, Rosario Meouchi, Anushka Irani   +2 more
wiley   +1 more source

AB1192 SARS-COV-2 VACCINE IN SPONDYLOARTHRITIS PATIENTS: OVERALL MODERATE/HIGH IMMUNOGENICITY IMPAIRED BY IMMUNOSUPPRESSANTS AND BIOLOGICAL THERAPY [PDF]

, 2022
Carla Gonçalves Schahin Saad, M. Rodrigues Silva, Percival D. Sampaio‐Barros, Júlio César Bertacini de Moraes, Cláudia Goldenstein‐Schainberg, Nádia Emi Aikawa, Erika Mendonça das Neves, Sandra Gofinet Pasoto, Tatiana do Nascimento Pedrosa, Renato K. Aoyama, Carlo Scognamiglio Renner Araújo, Cibele Costa Barreto da Silva, Ana Cristina de Medeiros Ribeiro, Eloísa Bonfá   +13 more
openalex   +1 more source

The role of IL-17A in axial spondyloarthritis and psoriatic arthritis: recent advances and controversies

Annals of the Rheumatic Diseases, 2019
Although the pathogenic mechanisms underlying axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA) are not fully elucidated, several lines of evidence suggest that immune responses mediated by interleukin 17A (IL-17A) play a pivotal role in both
D. McGonagle, I. McInnes, B. Kirkham, J. Sherlock, R. Moots   +4 more
semanticscholar   +1 more source

Rehabilitation Referral in Rheumatology: Insights From the RISE Registry

ACR Open Rheumatology, Volume 8, Issue 1, January 2026.
Objective The aim was to describe the percentage of patients with axial spondyloarthritis (axSpA), rheumatoid arthritis (RA), and systemic lupus erythematosus (SLE) in the Rheumatology Informatics System for Effectiveness (RISE) Registry who received a rehabilitation referral.
Astia Allenzara, Jing Li, Gabriela Schmajuk, Samannaaz S. Khoja, Louise M. Thoma   +4 more
wiley   +1 more source

AB1306 HOW DOES COVID-19 VACCINATION AFFECT DISEASE ACTIVITY AND SAFETY IN SECUKINUMAB TREATED PATIENTS WITH AXIAL SPONDYLOARTHRITIS? REAL WORLD DATA FROM THE GERMAN AQUILA STUDY [PDF]

, 2023
J. Brandt-Juergens, K. Gente, P. Kästner, D. Peterlik, Uta Kiltz   +4 more
openalex   +1 more source